IIBR-100
- Generic Name
- IIBR-100
Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- NeuroRx, Inc.
- Registration Number
- NCT04990466
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath